Pramodkumar P Gupta, Umesh Kumar, Manoj Kumar, Sanket Kaushik
{"title":"Classification of cancer biomarkers based on treatment strategies.","authors":"Pramodkumar P Gupta, Umesh Kumar, Manoj Kumar, Sanket Kaushik","doi":"10.1016/bs.acr.2024.07.002","DOIUrl":null,"url":null,"abstract":"<p><p>The term biomarkers defines a wide collection of biological indicators responsible for diagnosis, prognosis, and treatment outcome for an individual. In cancer, biomarkers are precise and valuable tool in diagnosis of early onset of neoplasm, diversity in oncologic conditions, heterogeneity in tumor and its micro-environment. As cancer treatment has shifted from high dosage and multiple therapy to precise and precision medicine, the role of biomarkers have been exponentially captured the therapeutic market. The cancer biomarkers ranges from diagnostic, prognostic, predictive, pharmacodynamic and monitoring to companion diagnostic biomarkers. The use of these biomarkers are very precise and strategically designed for the high efficacy and less toxic for the patient.</p>","PeriodicalId":94294,"journal":{"name":"Advances in cancer research","volume":"170 ","pages":"37-67"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in cancer research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/bs.acr.2024.07.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/29 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The term biomarkers defines a wide collection of biological indicators responsible for diagnosis, prognosis, and treatment outcome for an individual. In cancer, biomarkers are precise and valuable tool in diagnosis of early onset of neoplasm, diversity in oncologic conditions, heterogeneity in tumor and its micro-environment. As cancer treatment has shifted from high dosage and multiple therapy to precise and precision medicine, the role of biomarkers have been exponentially captured the therapeutic market. The cancer biomarkers ranges from diagnostic, prognostic, predictive, pharmacodynamic and monitoring to companion diagnostic biomarkers. The use of these biomarkers are very precise and strategically designed for the high efficacy and less toxic for the patient.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
